Additional Ventures Innovation Fund Single Ventricle Disease Research Program
The Stanford Maternal and Child Health Research Institute (MCHRI) Additional Ventures Single Ventricle Innovation Research Program aims to promote truly innovative research to treat and functionally cure single ventricle heart disease.
A single ventricle is a congenital heart defect that occurs due to abnormal development of the fetal heart during the first eight weeks of pregnancy. There are many types of single ventricles including double inlet left ventricle, hypoplastic left heart syndrome, mitral atresia, tricuspid atresia, and common AV valves with only one well-developed ventricle. Learn more.
The Additional Ventures Innovation Fund Single Ventricle Disease Research Program aims to accelerate scientific discoveries and development of treatments for single ventricle heart defects (SVDs).
Research in Single Ventricle Heart Defects
The Additional Ventures Innovation Fund Single Ventricle Disease Research Program supports a wide range of scientific approaches from basic, clinical, translational, engineering, information and other biomedical sciences to better understand the root causes of SVDs and to develop functional cures for those living with this condition.
The goal of each Additional Ventures Innovation Funds is to spark innovative and unique research ideas, to engage new members into the single ventricle and Fontan community, and to accelerate progress towards 1) understanding the underlying etiology of single ventricle heart defects and 2) developing functional cures for SVDS or for those with the Fontan circulation. Learn more.